Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0AT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,773
Award facts
- Contract value 100% obligated
- $41,773.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $41,773.15. This is a firm fixed price delivery order with a completion date of December 8, 2025, and no set-aside designation was utilized in the award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Department of Defense and its medical supply chain. The company's federal contract portfolio demonstrates extensive experience supplying a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, from brand-name and generic medications to specialized medical devices and vaccines. All reviewed contract awards have been competitively awarded and non-set-aside, reflecting the company's capability to meet rigorous federal procurement standards. The DLA plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FR0AT?
SPE2DR26FR0AT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FR0AT worth?
The government has obligated $41,773 on SPE2DR26FR0AT.
Is contract SPE2DR26FR0AT an order under another contract?
Yes. SPE2DR26FR0AT is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0AT competed?
The extent of competition for SPE2DR26FR0AT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award